✦ LIBER ✦

Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer

✍ Scribed by Bruce Montgomery; Philip Lavori; Mark Garzotto; Kelvin Lee; Mary Brophy; Surai Thaneemit-Chen; William Kelly; Joseph Basler; Robert Ringer; Wei Yu; Alice Whittemore; Daniel W. Lin

Book ID: 116949265
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 148 KB
Volume: 72
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2008.02.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Adjuvant Weekly Docetaxel for Patien

Re: Adjuvant Weekly Docetaxel for Patients with High Risk Prostate Cancer after Radical Prostatectomy: A Multi-institutional Pilot Study

✍ Derek Raghavan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Cancer and Leukemia Group B (CALGB) 9020

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease

✍ James A Eastham; William K Kelly; Gary D Grossfeld; Eric J Small 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Re: Multicenter Phase II Study of Combin

Re: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy before Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer

✍ P. Beuzeboc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 94 KB

The Prostate cancer Intervention Versus

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): Design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer

✍ Timothy J. Wilt; Michael K. Brawer; Michael J. Barry; Karen M. Jones; Young Kwon 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 377 KB

Adjuvant weekly docetaxel for patients w

Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: A multi-institutional pilot study: Kibel AS, Rosenbaum E, Kattan MW, Picus J, Dreicer R, Klein EA, Chatta GS, Nelson JB, DiPaola RS, Roth BJ, Cookson MS, Wilding G, Jarrard DF, Beer TM, Ryan CW, Petrylak DP, Benson MC, Partin AW, Garrett-Mayer E, Eisenberger MA, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO

✍ Daniel Wei Lin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB